The Interplay Between Blood Proteins, Complement, and Macrophages on Nanomedicine Performance and Responses
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
In the blood, depending on their physicochemical characteristics, nanoparticles attract a wide range of plasma biomolecules. The majority of blood biomolecules bind nonspecifically to nanoparticles. On the other hand, biomolecules such as pattern-recognition complement-sensing proteins may recognize some structural determinants of the pristine surface, causing complement activation. Adsorption of nonspecific blood proteins could also recruit natural antibodies and initiate complement activation, and this seems to be a global process with many preclinical and clinical nanomedicines. We discuss these issues, since complement activation has ramifications in nanomedicine stability and pharmacokinetics, as well as in inflammation and disease progression. Some studies have also predicted a role for complement systems in infusion-related reactions, whereas others show a direct role for macrophages and other immune cells independent of complement activation. We comment on these discrepancies and suggest directions for exploring the underlying mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918 · cited 4×
“macrophage receptors (and/or internalized through different routes) (Gratton et al., 2008).”
BackgroundInfluentialRapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., Reinhardt, C., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.181 · Cited by 2,283
Schöttler, S., Becker, G., Winzen, S., Steinbach, T., Mohr, K., Landfester, K., Mailänder, V., & Wurm, F. R. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2015.330 · Cited by 1,272 · cited 1×
“, 2001), but in some studies such surface modification processes has also attracted blood dysopsonic molecules to further overcome nanoparticle recognition by macrophages (Moghimi & Patel, 1993; Moghimi et al., 1993b; Schottler et al., 2016).”
BackgroundComplement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo
Chen, F., Wang, G., Griffin, J. I., Brenneman, B., Banda, N. K., Holers, V. M., Backos, D. S., Wu, L., Moghimi, S. M., & Simberg, D. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2016.269 · Cited by 599 · cited 3×
“Notwithstanding, C3 opsonization has also been shown to be continuous and changeable in vivo; complexes formed between C3 and corona proteins are released from nanoparticle surfaces and formed again on fresh protein deposition (Chen et al., 2017).”
BackgroundSelf-citationComplement and Its Receptors: New Insights into Human Disease
Holers, V. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120154 · Cited by 430 · cited 15×
“…system further comprises soluble and membrane-bound regulatory molecules such as C1-inhibitor, complement protein 4–binding protein, factors H and I, decay accelerating factor, and CD46 that modulate the extent of complement activation (Sjöberg et al., 2009; Ricklin et al., 2010; Holers, 2014).”
BackgroundInfluentialComplement activation and inhibition: a delicate balance
Sjöberg, A. P., Trouw, L. A., & Blom, A. M. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.11.003 · Cited by 364 · cited 1×
“…system further comprises soluble and membrane-bound regulatory molecules such as C1-inhibitor, complement protein 4–binding protein, factors H and I, decay accelerating factor, and CD46 that modulate the extent of complement activation (Sjöberg et al., 2009; Ricklin et al., 2010; Holers, 2014).”
BackgroundStructural basis for sialic acid–mediated self-recognition by complement factor H
Blaum, B. S., Hannan, J. P., Herbert, A. P., Kavanagh, D., Uhrín, D., & Stehle, T. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1696 · Cited by 278
Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption
Guan, J., Shen, Q., Zhang, Z., Jiang, Z., Yang, Y., Lou, M., Qian, J., Lu, W., & Zhan, C. (2018) · Nature Communications · doi:10.1038/s41467-018-05384-1 · Cited by 152 · cited 2×
“…and disease progression, there have been concerted efforts in engineering of targetable nanomedicines that do not trigger complement activation (Gbadamosi et al., 2002; Sou and Tsuchida, 2008; Wu et al., 2011; Andersen et al., 2013a; Wibroe et al., 2015; Azmi et al., 2016; Guan et al., 2018).”
BackgroundComplementing the sugar code: Role of GAGs and sialic acid in complement regulation
Langford-Smith, A., Day, A. J., Bishop, P. N., & Clark, S. J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00025 · Cited by 80 · cited 2×
“of surface expression of sialyated glycans and polysialic acid (Langford-Smith et al., 2015).”
Background
Cited by
The protein corona from nanomedicine to environmental science
Mahmoudi, M., Landry, M. P., Moore, A., & Coreas, R. (2023) · Nature Reviews Materials · doi:10.1038/s41578-023-00552-2 · Cited by 625
Chen, B.-M., Cheng, T.-L., & Roffler, S. R. (2021) · ACS Nano · doi:10.1021/acsnano.1c05922 · Cited by 563
The effects of protein corona on in vivo fate of nanocarriers
Xiao, Q., Zoulikha, M., Qiu, M., Teng, C., Lin, C., Li, X., Sallam, M. A., Xu, Q., & He, W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114356 · Cited by 255
Padín-González, E., Lancaster, P., Bottini, M., Gasco, P., Tran, L., Fadeel, B., Wilkins, T., & Monopoli, M. P. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.882363 · Cited by 166
The impact of protein corona on the biological behavior of targeting nanomedicines
Farshbaf, M., Valizadeh, H., Panahi, Y., Fatahi, Y., Chen, M., Zarebkohan, A., & Gao, H. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121458 · Cited by 95
Metadata
- Authors
- Moghimi, S. M., Simberg, D., Skotland, T., Yaghmur, A., & Hunter, A. C.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 370
- Issue
- 3
- Pages
- 581-592
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2933799428
- Cited by
- 64
- References
- 10
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Interplay Between Blood Proteins, Complement, and Macrophages on Nanomedicine Performance and Responses. https://app.cochat.ai/papers/10.1124/jpet.119.258012
- The paper
- Moghimi, S. M., Simberg, D., Skotland, T., Yaghmur, A., & Hunter, A. C. (2019). The Interplay Between Blood Proteins, Complement, and Macrophages on Nanomedicine Performance and Responses. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.119.258012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.